Hematopoietic SH2 Domain Containing (HSH2D) (Middle Region) Peptid
HSH2D
Reaktivität: Human
Wirt: Synthetic
BP, WB
Produktnummer ABIN5673288
Kurzübersicht für Hematopoietic SH2 Domain Containing (HSH2D) (Middle Region) Peptid (ABIN5673288)
Target
HSH2D
(Hematopoietic SH2 Domain Containing (HSH2D))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequenz
- VISGPGTGKG SQDHSGDPTS GDRGYTDPCV ATSLKSPSQP QAPKDRKVPT
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- HSH2D Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- HSH2D (Hematopoietic SH2 Domain Containing (HSH2D))
-
Hintergrund
-
T-cell activation requires 2 signals: recognition of antigen by the T-cell receptor and a costimulatory signal provided primarily by CD28 (MIM 186760) in naive T cells. HSH2 is a target of both of these signaling pathways.
Alias Symbols: ALX, HSH2
Protein Size: 295 -
Gen-ID
- 84941
-
NCBI Accession
- NM_001291274, NP_001278203
Target
-
Sie sind hier:
